Selected research
Market Analysis & Forecast
Global Morning-after Pill Market Analysis and Forecast 2026-2032
Market perspective
The global Morning-after Pill market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Morning-after Pill is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Morning-after Pill is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Morning-after Pill is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Morning-after Pill is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Morning-after Pill include Zizhu Pharma, Zhejiang Xianju Pharma, Syzygy Healthcare, Regenex, Piramal, Mankind Pharma, Lupin, HRA Pharma and HLL Life Care, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Morning-after Pill, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Morning-after Pill, also provides the sales of main regions and countries. Of the upcoming market potential for Morning-after Pill, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Morning-after Pill sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Morning-after Pill market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Morning-after Pill sales, projected growth trends, production technology, application and end-user industry.
Morning-after Pill Segment by Company
Zizhu Pharma
Zhejiang Xianju Pharma
Syzygy Healthcare
Regenex
Piramal
Mankind Pharma
Lupin
HRA Pharma
HLL Life Care
Gedeon Richter
Foundation Consumer Healthcare
Morning-after Pill Segment by Type
Levonorgestrel
Ulipristal Acetate
Morning-after Pill Segment by Application
Online
Offline
Morning-after Pill Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morning-after Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Morning-after Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morning-after Pill.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Morning-after Pill in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Morning-after Pill manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morning-after Pill sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel
- Ulipristal Acetate
Applications
- Online
- Offline
Companies covered
- Zizhu Pharma
- Zhejiang Xianju Pharma
- Syzygy Healthcare
- Regenex
- Piramal
- Mankind Pharma
- Lupin
- HRA Pharma
- HLL Life Care
- Gedeon Richter
- Foundation Consumer Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Morning-after Pill Market by Type
- 1.2.1 Global Morning-after Pill Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Levonorgestrel
- 1.2.3 Ulipristal Acetate
- 1.3 Morning-after Pill Market by Application
- 1.3.1 Global Morning-after Pill Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Online
- 1.3.3 Offline
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Morning-after Pill Market Dynamics
- 2.1 Morning-after Pill Industry Trends
- 2.2 Morning-after Pill Industry Drivers
- 2.3 Morning-after Pill Industry Opportunities and Challenges
- 2.4 Morning-after Pill Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Morning-after Pill Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Morning-after Pill Revenue by Region
- 3.2.1 Global Morning-after Pill Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Morning-after Pill Revenue by Region (2021-2026)
- 3.2.3 Global Morning-after Pill Revenue by Region (2027-2032)
- 3.2.4 Global Morning-after Pill Revenue Market Share by Region (2021-2032)
- 3.3 Global Morning-after Pill Sales Estimates and Forecasts 2021-2032
- 3.4 Global Morning-after Pill Sales by Region
- 3.4.1 Global Morning-after Pill Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Morning-after Pill Sales by Region (2021-2026)
- 3.4.3 Global Morning-after Pill Sales by Region (2027-2032)
- 3.4.4 Global Morning-after Pill Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Morning-after Pill Revenue by Manufacturers
- 4.1.1 Global Morning-after Pill Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Morning-after Pill Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Morning-after Pill Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Morning-after Pill Sales by Manufacturers
- 4.2.1 Global Morning-after Pill Sales by Manufacturers (2021-2026)
- 4.2.2 Global Morning-after Pill Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Morning-after Pill Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Morning-after Pill Sales Price by Manufacturers (2021-2026)
- 4.4 Global Morning-after Pill Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Morning-after Pill Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Morning-after Pill Manufacturers, Product Type & Application
- 4.7 Global Morning-after Pill Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Morning-after Pill Market CR5 and HHI
- 4.8.2 2025 Morning-after Pill Tier 1, Tier 2, and Tier 3
5 Morning-after Pill Market by Type
- 5.1 Global Morning-after Pill Revenue by Type
- 5.1.1 Global Morning-after Pill Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Morning-after Pill Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Morning-after Pill Revenue Market Share by Type (2021-2032)
- 5.2 Global Morning-after Pill Sales by Type
- 5.2.1 Global Morning-after Pill Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Morning-after Pill Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Morning-after Pill Sales Market Share by Type (2021-2032)
- 5.3 Global Morning-after Pill Price by Type
6 Morning-after Pill Market by Application
- 6.1 Global Morning-after Pill Revenue by Application
- 6.1.1 Global Morning-after Pill Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Morning-after Pill Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Morning-after Pill Revenue Market Share by Application (2021-2032)
- 6.2 Global Morning-after Pill Sales by Application
- 6.2.1 Global Morning-after Pill Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Morning-after Pill Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Morning-after Pill Sales Market Share by Application (2021-2032)
- 6.3 Global Morning-after Pill Price by Application
7 Company Profiles
- 7.1 Zizhu Pharma
- 7.1.1 Zizhu Pharma Company Information
- 7.1.2 Zizhu Pharma Business Overview
- 7.1.3 Zizhu Pharma Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Zizhu Pharma Morning-after Pill Product Portfolio
- 7.1.5 Zizhu Pharma Recent Developments
- 7.2 Zhejiang Xianju Pharma
- 7.2.1 Zhejiang Xianju Pharma Company Information
- 7.2.2 Zhejiang Xianju Pharma Business Overview
- 7.2.3 Zhejiang Xianju Pharma Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Zhejiang Xianju Pharma Morning-after Pill Product Portfolio
- 7.2.5 Zhejiang Xianju Pharma Recent Developments
- 7.3 Syzygy Healthcare
- 7.3.1 Syzygy Healthcare Company Information
- 7.3.2 Syzygy Healthcare Business Overview
- 7.3.3 Syzygy Healthcare Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Syzygy Healthcare Morning-after Pill Product Portfolio
- 7.3.5 Syzygy Healthcare Recent Developments
- 7.4 Regenex
- 7.4.1 Regenex Company Information
- 7.4.2 Regenex Business Overview
- 7.4.3 Regenex Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Regenex Morning-after Pill Product Portfolio
- 7.4.5 Regenex Recent Developments
- 7.5 Piramal
- 7.5.1 Piramal Company Information
- 7.5.2 Piramal Business Overview
- 7.5.3 Piramal Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Piramal Morning-after Pill Product Portfolio
- 7.5.5 Piramal Recent Developments
- 7.6 Mankind Pharma
- 7.6.1 Mankind Pharma Company Information
- 7.6.2 Mankind Pharma Business Overview
- 7.6.3 Mankind Pharma Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Mankind Pharma Morning-after Pill Product Portfolio
- 7.6.5 Mankind Pharma Recent Developments
- 7.7 Lupin
- 7.7.1 Lupin Company Information
- 7.7.2 Lupin Business Overview
- 7.7.3 Lupin Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Lupin Morning-after Pill Product Portfolio
- 7.7.5 Lupin Recent Developments
- 7.8 HRA Pharma
- 7.8.1 HRA Pharma Company Information
- 7.8.2 HRA Pharma Business Overview
- 7.8.3 HRA Pharma Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 HRA Pharma Morning-after Pill Product Portfolio
- 7.8.5 HRA Pharma Recent Developments
- 7.9 HLL Life Care
- 7.9.1 HLL Life Care Company Information
- 7.9.2 HLL Life Care Business Overview
- 7.9.3 HLL Life Care Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 HLL Life Care Morning-after Pill Product Portfolio
- 7.9.5 HLL Life Care Recent Developments
- 7.10 Gedeon Richter
- 7.10.1 Gedeon Richter Company Information
- 7.10.2 Gedeon Richter Business Overview
- 7.10.3 Gedeon Richter Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Gedeon Richter Morning-after Pill Product Portfolio
- 7.10.5 Gedeon Richter Recent Developments
- 7.11 Foundation Consumer Healthcare
- 7.11.1 Foundation Consumer Healthcare Company Information
- 7.11.2 Foundation Consumer Healthcare Business Overview
- 7.11.3 Foundation Consumer Healthcare Morning-after Pill Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Foundation Consumer Healthcare Morning-after Pill Product Portfolio
- 7.11.5 Foundation Consumer Healthcare Recent Developments
8 North America
- 8.1 North America Morning-after Pill Market Size by Type
- 8.1.1 North America Morning-after Pill Revenue by Type (2021-2032)
- 8.1.2 North America Morning-after Pill Sales by Type (2021-2032)
- 8.1.3 North America Morning-after Pill Price by Type (2021-2032)
- 8.2 North America Morning-after Pill Market Size by Application
- 8.2.1 North America Morning-after Pill Revenue by Application (2021-2032)
- 8.2.2 North America Morning-after Pill Sales by Application (2021-2032)
- 8.2.3 North America Morning-after Pill Price by Application (2021-2032)
- 8.3 North America Morning-after Pill Market Size by Country
- 8.3.1 North America Morning-after Pill Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Morning-after Pill Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Morning-after Pill Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Morning-after Pill Market Size by Type
- 9.1.1 Europe Morning-after Pill Revenue by Type (2021-2032)
- 9.1.2 Europe Morning-after Pill Sales by Type (2021-2032)
- 9.1.3 Europe Morning-after Pill Price by Type (2021-2032)
- 9.2 Europe Morning-after Pill Market Size by Application
- 9.2.1 Europe Morning-after Pill Revenue by Application (2021-2032)
- 9.2.2 Europe Morning-after Pill Sales by Application (2021-2032)
- 9.2.3 Europe Morning-after Pill Price by Application (2021-2032)
- 9.3 Europe Morning-after Pill Market Size by Country
- 9.3.1 Europe Morning-after Pill Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Morning-after Pill Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Morning-after Pill Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Morning-after Pill Market Size by Type
- 10.1.1 China Morning-after Pill Revenue by Type (2021-2032)
- 10.1.2 China Morning-after Pill Sales by Type (2021-2032)
- 10.1.3 China Morning-after Pill Price by Type (2021-2032)
- 10.2 China Morning-after Pill Market Size by Application
- 10.2.1 China Morning-after Pill Revenue by Application (2021-2032)
- 10.2.2 China Morning-after Pill Sales by Application (2021-2032)
- 10.2.3 China Morning-after Pill Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Morning-after Pill Market Size by Type
- 11.1.1 Asia Morning-after Pill Revenue by Type (2021-2032)
- 11.1.2 Asia Morning-after Pill Sales by Type (2021-2032)
- 11.1.3 Asia Morning-after Pill Price by Type (2021-2032)
- 11.2 Asia Morning-after Pill Market Size by Application
- 11.2.1 Asia Morning-after Pill Revenue by Application (2021-2032)
- 11.2.2 Asia Morning-after Pill Sales by Application (2021-2032)
- 11.2.3 Asia Morning-after Pill Price by Application (2021-2032)
- 11.3 Asia Morning-after Pill Market Size by Country
- 11.3.1 Asia Morning-after Pill Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Morning-after Pill Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Morning-after Pill Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Morning-after Pill Market Size by Type
- 12.1.1 SAMEA Morning-after Pill Revenue by Type (2021-2032)
- 12.1.2 SAMEA Morning-after Pill Sales by Type (2021-2032)
- 12.1.3 SAMEA Morning-after Pill Price by Type (2021-2032)
- 12.2 SAMEA Morning-after Pill Market Size by Application
- 12.2.1 SAMEA Morning-after Pill Revenue by Application (2021-2032)
- 12.2.2 SAMEA Morning-after Pill Sales by Application (2021-2032)
- 12.2.3 SAMEA Morning-after Pill Price by Application (2021-2032)
- 12.3 SAMEA Morning-after Pill Market Size by Country
- 12.3.1 SAMEA Morning-after Pill Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Morning-after Pill Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Morning-after Pill Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Morning-after Pill Value Chain Analysis
- 13.1.1 Morning-after Pill Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Morning-after Pill Production Mode & Process
- 13.2 Morning-after Pill Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Morning-after Pill Distributors
- 13.2.3 Morning-after Pill Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst